Search results
Story from Associated Retina Consultants: Local group helps macular degeneration patients cope with...
The Arizona Republic· 2 days agoAccording to the Centers for Disease Control and Prevention (CDC), nearly 20 million Americans over...
Breakthrough Study Reveals Somavedic Device's Potential Impact on Wet AMD Patients
WLNS Lansing· 5 days agoSomavedic, a trailblazer in sleep and digital pollution-neutralizing frequency therapy technology, in collaboration with researchers from the Eye Clinic of Jan Evangelista ...
...Proprietary OPC Platform Targeting Ocular Diseases at the upcoming Association for Research in...
WKRN Nashville· 5 days ago("WincalBio"), will present preclinical findings on its innovative ocular drug delivery platform at the upcoming conference, Association for Research in Vision and Ophthalmology ...
Top 20 biopharma kick off 9.6% market cap surge in Q1 2024 amid Medicare price talks
Pharmaceutical Technology via Yahoo Finance· 2 days agoHowever, Roche’s market capitalisation fell by 12.4%, largely attributed to the decline in demand...
RevOpsis Secures $16.5 Million Seed Funding to Advance First-in-Class Tri-Specific Therapy for...
WDTN-TV 2 Dayton· 3 days agoThis seed round will also support the ongoing discovery and development of RevOpsis' pipeline, and allow the company to hire key management to drive the company forward.
Signet Financial Management LLC Sells 187 Shares of Johnson & Johnson (NYSE:JNJ)
ETF DAILY NEWS· 6 days agoSignet Financial Management LLC cut its holdings in Johnson & Johnson (NYSE:JNJ – Free Report) by 1.2% during the fourth quarter, according to the company in its most recent Form 13F filing ...
The murky, unregulated world of anti-ageing stem cell therapy
The Telegraph via Yahoo News· 4 days agoStem cells are the new focal point of the rich and famous with Hollywood A-listers reportedly...
Restoring sight is possible now with optogenetics
Washington Post· 5 days agoAs a child, Max Hodak learned to develop film in a darkroom with his late grandfather who was almost blind. Hodak’s grandfather had retinitis pigmentosa,...
Oculis (NASDAQ:OCS) Price Target Cut to $28.00
ETF DAILY NEWS· 2 days agoOculis (NASDAQ:OCS – Get Free Report) had its price target dropped by research analysts at HC Wainwright from $29.00 to $28.00 in a research note issued ...
Health Care Roundup: Market Talk
The Wall Street Journal· 5 days agoMoreover, its planned launch of aflibercept—for patients living with wet macular degeneration—could be a potentially significant biosimilar opportunity,...
